Celia Sabry-Grant, MSc

Celia is a Health Outcomes Associate. Since joining Symmetron in February 2018, she has gained experience in screening, data extraction, quality assessment and report writing for systematic reviews. Celia has an MSc in Public Health Nutrition from the University of Westminster, from which she graduated in 2014. Since graduating Celia has worked as a Nutritionist in foodservice, spent time volunteering with Action on Sugar and carried out research on cancer epidemiology and alcohol consumption.

Publications

Rohr K, Baldwin M, Sabry-Grant C, Langford B, Salih F, Diamantopoulos A, Cottin V. Systematic Literature Review of Treatments for Interstitial Lung Disease in Patients with a Progressive Fibrosing Phenotype. Value in Health. 2020: 23;S716.

Sabry-Grant, C., Malottki, K., Diamantopoulos, A. The Cancer Drugs Fund in Practice and Under the New Framework. PharmacoEconomics 2019;37: 953-962.

Laura M. Sawyer, Kinga Malottki, Celia Sabry-Grant, Najeeda Yasmeen, Emily Wright, Anne Sohrt, Emma Borg, Richard B. Warren. Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response. PLOS ONE 2019 14(8);e0220868.

Presentations

Sawyer L, Malottki K, Yasmeen N, Wright E, Sabry-Grant C, Sohrt A, Ziegler F, Warren R. Interleukin-17 and interleukin-23 targeted treatments for moderate to severe plaque psoriasis:  a systematic review and network meta-analysis of PASI response (poster). European Academy of Dermatology and Venerology 27th Congress, 12-16 September 2018, Paris, France.